Mesentech has developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue. The advantage of our technology is that exposure to the active pharmaceutical occurs only in the targeted tissues, thereby eliminating toxicity to unrelated organs.
Our first product harnesses tissue-targeting technology to deliver prostaglandin, a potent hormone that triggers the body's own regenerative process, to renew and repair bone. It's safety profile would support its use not only in osteoporosis but also in certain pediatric osteoporosis diseases.
Mesentech has developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue. The advantage of our technology is that exposure to the active pharmaceutical occurs only in the targeted tissues, thereby eliminating toxicity to unrelated organs.
Our first product harnesses tissue-targeting technology to deliver prostaglandin, a potent hormone that triggers the body's own regenerative process, to renew and repair bone. It's safety profile would support its use not only in osteoporosis but also in certain pediatric osteoporosis diseases.
